Table CS1: Consistent series of drug-related deaths - 'extra' deaths and which of the drugs that were present for each of the 'extra' deaths meant that they were counted in the consistent series: 2000 to 2016
20002001200220032004200520062007200820092010201120122013201420152016

Footnotes

  1. Broadly speaking, counting deaths on the basis of the classification of the drugs at the end of the latest year which is covered by the publication. Refer to Annex F for the full definition.
  2. Broadly speaking, counting deaths on the basis of the classification of the drugs at the time of death. Refer to Annex A for the full definition.
  3. This includes deaths which are counted in the consistent series but are not counted in the standard definition.
  4. Mephedrone has been a controlled substance with effect from 16 April 2010, so subsequent deaths involving it are counted in the 'standard definition' figures (and not 'extra' deaths).
  5. Phenazepam has been a controlled substance with effect from 13 June 2012, so subsequent deaths involving it are counted in the 'standard definition' figures (and not 'extra' deaths).
  6. Tramadol and zopiclone have been controlled substances with effect from 10 June 2014, so subsequent deaths involving either (or both) of them are counted in the 'standard definition' figures (and not 'extra' deaths).
  7. For example one or more of APB, API and BZP were present.

© Crown Copyright 2017
Drug-related deaths: consistent series1293339388330365346430474590570512606604557620707868
Drug-related deaths: standard definition2292332382317356336421455574545485584581527614706867
Extra' deaths counted in the consistent series3
of which:		17613910919162527222330611
Mephedrone4 present00000000003000000
Phenazepam5 present00000000000110000
Tramadol6 present0521289916141917121727300
Zopiclone6 present12411104267971000
None of the above, but one or more other substances which are now controlled were present700000000010012311